Lido Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.4M Buy
45,822
+11,590
+34% +$5.16M 0.08% 143
2025
Q1
$16.6M Buy
34,232
+2,626
+8% +$1.27M 0.07% 155
2024
Q4
$12.7M Buy
31,606
+7,207
+30% +$2.9M 0.06% 178
2024
Q3
$11.3M Buy
24,399
+335
+1% +$156K 0.06% 177
2024
Q2
$11.3M Buy
24,064
+530
+2% +$248K 0.06% 154
2024
Q1
$9.84M Sell
23,534
-89
-0.4% -$37.2K 0.06% 166
2023
Q4
$9.61M Sell
23,623
-15,330
-39% -$6.24M 0.06% 155
2023
Q3
$13.5M Buy
38,953
+21,761
+127% +$7.57M 0.1% 107
2023
Q2
$6.05M Sell
17,192
-7,087
-29% -$2.49M 0.04% 185
2023
Q1
$7.65M Sell
24,279
-3,953
-14% -$1.25M 0.07% 152
2022
Q4
$8.15M Buy
28,232
+12,234
+76% +$3.53M 0.1% 108
2022
Q3
$4.63M Buy
15,998
+11,851
+286% +$3.43M 0.06% 141
2022
Q2
$1.17M Buy
4,147
+92
+2% +$25.9K 0.02% 281
2022
Q1
$1.06M Buy
4,055
+712
+21% +$186K 0.01% 343
2021
Q4
$734K Buy
3,343
+1,013
+43% +$222K 0.01% 438
2021
Q3
$422K Buy
2,330
+295
+14% +$53.4K 0.01% 567
2021
Q2
$410K Buy
2,035
+216
+12% +$43.5K 0.01% 513
2021
Q1
$391K Sell
1,819
-130
-7% -$27.9K 0.01% 493
2020
Q4
$460K Buy
1,949
+130
+7% +$30.7K 0.01% 444
2020
Q3
$495K Buy
1,819
+211
+13% +$57.4K 0.01% 339
2020
Q2
$467K Buy
1,608
+128
+9% +$37.2K 0.01% 316
2020
Q1
$352K Buy
1,480
+45
+3% +$10.7K 0.02% 350
2019
Q4
$314K Buy
1,435
+25
+2% +$5.47K 0.01% 431
2019
Q3
$239K Buy
1,410
+15
+1% +$2.54K 0.01% 446
2019
Q2
$255K Buy
1,395
+26
+2% +$4.75K 0.01% 418
2019
Q1
$251K Sell
1,369
-22
-2% -$4.03K 0.02% 396
2018
Q4
$230K Buy
1,391
+18
+1% +$2.98K 0.02% 345
2018
Q3
$264K Buy
1,373
+49
+4% +$9.42K 0.03% 346
2018
Q2
$225K Sell
1,324
-1,333
-50% -$227K 0.03% 353
2018
Q1
$433K Buy
+2,657
New +$433K 0.06% 199